This site is new - feedback and suggestions welcome via GitHub issues.
0

Syndecan-1-targeted therapeutic antibody impairs macropinocytosis and elicits antitumor immunity in pancreatic cancer. (linkinghub.elsevier.com)

Authors: Yang Z … Yao W Journal: Cell Reports Medicine Published: 2026-02-17 DOI: https://doi.org/10.1016/j.xcrm.2026.102613
submitted by robot 6mo ago 0 comments
#metabolism #antibody #cancer #immunotherapy

Comments

No comments yet. Be the first!